openPR Logo
Press release

Deadline coming up on Sept. 27th in Lawsuit for Investors who lost money with Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares

A Deadline is coming up on September 27, 2024 in the lawsuit for certain investors in Lifecore Biomedical, Inc. (NASDAQ: LFCR).

A Deadline is coming up on September 27, 2024 in the lawsuit for certain investors in Lifecore Biomedical, Inc. (NASDAQ: LFCR).

A deadline is coming up on September 27, 2024 in the lawsuit filed for certain investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over alleged securities laws violations by Lifecore Biomedical, Inc.

Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) have certain options and there are strict and short deadlines running. Deadline: September 27, 2024. NASDAQ: LFCR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the District of Minnesota the plaintiff alleges on behalf of purchasers of Lifecore Biomedical, Inc. (NASDAQ: LFCR) common shares between October 7, 2020, and March 19, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between October 7, 2020, and March 19, 2024, the Defendants made false and/or misleading statements and/or failed to disclose tha) Lifecore maintained deficient internal controls over financial reporting, that as a result, the Company issued several financial statements that were inaccurate and would need to be restated, that Lifecore's purported remediation efforts with respect to the foregoing deficiencies were ineffective, that all of the foregoing impaired Lifecore's ability to timely file periodic reports with the SEC in compliance with NASDAQ listing requirements, that accordingly, the Company's financial position and/or prospects were materially overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline coming up on Sept. 27th in Lawsuit for Investors who lost money with Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares here

News-ID: 3658562 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of GitLab Inc. (NASDAQ: GTLB)
Lawsuit filed for Investors who lost money with shares of GitLab Inc. (NASDAQ: G …
An investor, who purchased shares of GitLab Inc. (NASDAQ: GTLB), filed a lawsuit over alleged violations of Federal Securities Laws by GitLab Inc. in connection with certain allegedly false and misleading statements made between June 6, 2023 and March 4, 2024. Investors who purchased shares of GitLab Inc. (NASDAQ: GTLB) have certain options and for certain investors are short and strict deadlines running. Deadline: November 4, 2024. NASDAQ: GTLB investors should
Investors who lost money with shares of Proto Labs, Inc. (NYSE: PRLB) should contact the Shareholders Foundation in connection with Investigation
Investors who lost money with shares of Proto Labs, Inc. (NYSE: PRLB) should con …
An investigation was announced on behalf of investors of Proto Labs, Inc. (NYSE: PRLB) shares over potential securities laws violations by Proto Labs, Inc. in connection with certain financial statements. Investors who purchased shares of Proto Labs, Inc. (NYSE: PRLB), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of
Investigation announced for Investors in DocGo Inc. (NASDAQ: DCGO) over potential Wrongdoing
Investigation announced for Investors in DocGo Inc. (NASDAQ: DCGO) over potentia …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at DocGo Inc. Investors who purchased shares of DocGo Inc. (NASDAQ: DCGO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain DocGo Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. DocGo Inc. reported that
Investigation Alert: Investors who lost money with shares of LPL Financial Holdings Inc. (NASDAQ: LPLA) should contact the Shareholders Foundation
Investigation Alert: Investors who lost money with shares of LPL Financial Holdi …
An investigation was announced for investors of LPL Financial Holdings Inc. (NASDAQ: LPLA) shares over potential securities laws violations by LPL Financial Holdings Inc. in connection with certain statements. Investors who purchased shares of LPL Financial Holdings Inc. (NASDAQ: LPLA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers

All 5 Releases


More Releases for Lifecore

Viscosupplementation Market 2019 - Major Participants Seikagaku Corporation, Fer …
Viscosupplementation Market Highlights: MRFR has segmented the global viscosupplementation market on the basis of various parameters in order to provide readers with a comprehensive overview of the market. The leading players and segments dominating the global viscosupplementation market are also profiled in the report. Viscosupplementation is a procedure used to refill the lubricating fluid in bone joints. Hyaluronic acid is a major component of viscosupplementation formulations, as hyaluronic acid is normally found
Global Sodium Hyaluronate Market - Contipro, Lifecore Biomedical, SEIKAGAKU Corp …
A fresh research report presented by KD Market Insights provides a detailed analysis of “Global Sodium Hyaluronate Market Size, Trends, Opportunity and Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business is going through. The research provides a complete
Global Sodium Hyaluronate Market - Contipro, Lifecore Biomedical, SEIKAGAKU Corp …
Sodium hyaluronate is fluid that surrounds the joints in the body. It is used to treat knee pain caused by osteoarthritis. They are made up of leaded crystal glass that is broken into a fine powder which can be used in all media to give colours for creating textual effects on the surface of paintings. According to the KD market Insights, the global sodium hyaluronate Market is expected to achieve notable
Sodium Hyaluronate Market Analysis: Top Companies Includes - Contipro, Lifecore …
Global Sodium Hyaluronate Market research Report explores the essential factors of the Sodium Hyaluronate Market considering such as industry situations, market demands, market players adopted business strategies and their growth scenario. The Global Sodium Hyaluronate Market has been separated by this report based on the key players profiles, Type, Application and Regions. The Sodium Hyaluronate Market report provides key information about the industry, including invaluable facts and figures, expert opinions, and
Healthcare News: Viscosupplementation Market Comprehensive Analysis on Key Playe …
The global Viscosupplementation market is anticipated to reach USD 6.6 billion by 2026 according to a new research report. Based on the assessments circulated by the World Health Organization, the worldwide people of the age of 65 years or more is estimated to ascend from 7% from 2000 to 16% till 2050. Viscosupplementation is a minimally invasive procedure helps reducing the joint ache and increases the efficient condition of the osteoarthritic
Insights on the Rower Market: Top Players - Concept2, WaterRower Machine, FIRST …
HTF MI recently introduced EMEA (Europe, Middle East and Africa) Rower Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Concept2, WaterRower Machine, FIRST DEGREE FITNESS, LifeCORE